
Tactile Systems (TCMD) Stock Forecast & Price Target
Tactile Systems (TCMD) Analyst Ratings
Bulls say
Tactile Systems Tech is set to see strong revenue growth in FY26, particularly in their Lymphedema and AffloVest products, with potential for continued growth through new product launches and exclusive distribution agreements. However, potential risks include slow adoption and competition, and the company must address challenges with Medicare changes. Overall, the company maintains a Buy rating and has shown strong earnings, with plans to continue growing through investments in sales and share repurchases.
Bears say
Tactile Systems Tech is facing several challenges that are impacting its growth potential. The recent Medicare prior authorization requirement has led to administrative burdens, limiting the potential growth of their products. Additional risks include competition in the Airway Clearance business and potential limitations on sales force leverage. Overall, these challenges may hinder their ability to achieve desired top-line growth, leading to a negative outlook for the company's stock.
This aggregate rating is based on analysts' research of Tactile Systems and is not a guaranteed prediction by Public.com or investment advice.
Tactile Systems (TCMD) Analyst Forecast & Price Prediction
Start investing in Tactile Systems (TCMD)
Order type
Buy in
Order amount
Est. shares
0 shares